Watch AMR& Diagnostic Frontiers Event with CARB-X and FIND

04 Mar 2022

The Longitude Prize joined forces with FIND and CARB-X yesterday to bring the Antimicrobial Resistance (AMR) diagnostics community a virtual event: AMR& Diagnostic Frontiers: developing and increasing access to AMR diagnostics in low-and-middle-income countries (LMICs).

Today – on World Engineering Day – we share the recording from the event where we heard successful LMIC diagnostic development models from experts in Morocco, India and Senegal, followed by a session on the technology pipeline with diagnostic companies and global health experts.

This World Engineering Day, we want to celebrate and highlight engineering achievements and improve public understanding of how engineering and technology are central to modern life, health and for sustainable development across the globe.

Covid-19 has highlighted the value of diagnostic technologies to global healthcare and society. For many years, innovators have been developing and refining the next generation of rapid antimicrobial resistance (AMR) diagnostic tests. The Global Research on Antimicrobial Resistance (GRAM) study in the Lancet revealed that AMR has become a leading cause of death worldwide, with more than 1.2 million people dying as a direct result of antibiotic drug-resistant bacterial infections in 2019. At the end of 2021, The Lancet Commission on Diagnostics found that a staggering 47% of the global population have little to no access to diagnostics.

There is both a need to increase access to appropriately-designed diagnostics developed in high-income countries (HICs) for low-and middle-income countries (LMICs) and to locally develop more products in and for LMICs. To achieve commercial success and build a sustainable business, most diagnostic developers focus on tests that suit HICs, although not an issue unique to novel AMR diagnostics.

AMR& Diagnostic Frontiers brought diagnostic developers together with global health experts to discuss the manufacturing adaptation of and development of homegrown AMR diagnostics. The event included successful diagnostic stories developed locally in Morocco, India and Senegal.  Please see the full list of speakers and panelists below.

Also on this topic, check out the Longitude Prize guide How to make AMR diagnostics globally applicable in LMIC settings for diagnostic developers.

AMR& Diagnostic Frontiers

Chair: Bill Rodriguez, CEO, FIND

Dr. Patty Garcia, Professor, Universidad Peruana Cayetano Heredia, Peru (UPCH) and Commissioner, Lancet Commission on Diagnostics shared key highlights and recommendations from the Lancet Commission published in October 2021.

Chair: Bill Rodriguez, CEO, FIND

Diagnostic developers shared successful models and stories of the development, adaptation and rollout of diagnostics in an LMIC setting – and their perspectives on how, looking ahead, LMICs can build homegrown innovation capacity to deliver accessible, rapid diagnostics.

Speakers:

  • Prof. Hassan Sefrioui, Director & Member of the Executive Board at Moroccan foundation for Advanced Science, Innovation and Research (MAScIR), Morocco
  • Dr Shirshendu Mukherjee, Mission Director, Grand Challenges India (DBT-BIRAC-BMGF-Wellcome Trust) and Biotechnology Industry Research Assistance Council (BIRAC), India
  • Cheikh Tidiane Diagne, Head of Operations, diaTROPIX, of the Institut Pasteur de Dakar, Senegal

Companies developing AMR diagnostics for an LMIC setting presented their products to a panel of global health representatives who shared customer-driven feedback on their technology, access and pathway to market.

Chair: Erin Duffy, Chief of Research and Development, CARB-X

Presentees:

Panel:

  • Alex Costa, Health Programme Manager, UNICEF
  • David Ripin, EVP Infectious Diseases & Chief Science Officer, Clinton Health Access Initiative (CHAI)
  • Jenny Molloy, University of Cambridge and Working Group on Diagnostics and Local Production (Chair)
  • Katerina Galluzzo, Strategy Manager, Unitaid
  • Jorge Matheu, Team Lead and AMR laboratory expert, World Health Organization (WHO)
  • Otridah Kapona, Infectious Diseases Specialist, Zambia National Public Health Institute (ZNPHI) / AMR Nat. Focal Point & Coordinator, Zambia

Erin Duffy, CARB-X

Catch up on the event by watching this recording

Our latest news & views

A Technical Read: Improved UTI Diagnostics: AST without Identification – Ready for “Primetime”?

Blog

AMR& Diagnostic Frontiers: Virtual Event on 3 March (with CARB-X & FIND)

Event

Ensuring access to tackle the growing global threat of antimicrobial resistance

Blog

Meet the Judges: Prof Hassan Sefrioui, Director and Member of the Executive Board at Moroccan Foundation for Advanced Science, Innovation and Research

Blog

Meet the Judges: Dr Direk Limmathurotsakul, Head of Microbiology at Mahidol-Oxford Tropical Medicine Research Unit

Blog

Meet the Judges: Dr Tom Boyles, Specialist in Infectious Diseases and HIV Medicine

Blog

An Intro to the NICE Diagnostics Assessment Programme from Becky Albrow: what did we learn?

Blog

Q&A with Jeff Featherstone, Head of AMR at the NHS

Blog